Not Tagged
Not Tagged
['mds']
congress | #asco23 | adeola y. makinde presented clinical outcomes by sf3b1 mutation status in pts with lr-mds retreated with erythropoiesis-stimulating agents (esa). esa failure was high in retreated pts &amp; os was poor regardless of sf3b1 status. #mdssm #medicalcongress 
Lifting levels of knowledge in myelodysplastic syndromes (#MDS). A global online platform providing latest treatment options and medical information. #mdssm